Parthenolide as a therapeutic for disseminated canine neoplasms [Drug Discovery and Translational Medicine]
ASPET
DECEMBER 22, 2023
This study provides a unique translational research opportunity to help both humans and dogs diagnosed with diseases that carry dismal prognoses in both species: histiocytic sarcoma (HS), hemangiosarcoma (HSA), and disseminated mastocytosis/mast cell tumor (MCT). While exceedingly rare in humans, these so called "orphan diseases" are relatively more common in dogs.
Let's personalize your content